Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Rose 31.4% in First Three Quarters of 2022

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 1.4 billion yuan in the first three quarters of 2022, up 31.4% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, down 14.5% year-on-year.

At the end of the reporting period, it had 6.9 billion yuan in total assets and 528.6 million yuan in total liabilities, with a liability-to-asset ratio of 7.7%.